BK
Bhupender Kumar
About Bhupender Kumar
Data last updated:
Bhupender Kumar is a Director at Yatnesh Pharma Private Limited (since 2013), Director at Bsa Tradex Private Limited (since 2018) and Designated Partner at Neelkanth Pharmaceuticals Llp (since 2025), and holds 2 more current directorships. The companies operate in Pharma and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹77.67 Cr; the largest is Yatnesh Pharma Private Limited at ₹69.60 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Yatnesh Pharma Private Limited U85100DL2013PTC255862 | Director | 25 Jul 2013 | 2013 | ₹69.60 Cr (FY 2025) | Active |
| Bsa Tradex Private Limited U74999DL2018PTC343507 | Director | 26 Dec 2018 | 2018 | ₹8.06 Cr (FY 2025) | Active |
| Neelkanth Pharmaceuticals Llp ACT-6482 | Designated Partner | 19 Dec 2025 | 2025 | Active | |
| Neelkanth Biotech Private Limited U46497DL2025PTC442307 | Director | 07 Feb 2025 | 2025 | Active | |
| Jabs Healthcare Private Limited U85190HR2022PTC105002 | Director | 07 Jul 2022 | 2022 | Active |
Board colleagues of Bhupender Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bimla Garg | 09378445 | Yatnesh Pharma Private Limited | Director |
| Sanjeev Gupta | 08313785 | Bsa Tradex Private Limited , Jabs Healthcare Private Limited | Director |
| Jitender | 09665897 | Neelkanth Pharmaceuticals Llp , Neelkanth Biotech Private Limited and 1 more | Designated Partner |
| Ashwani Garg | 07010826 | Jabs Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhupender Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhupender Kumar
Bhupender Kumar currently holds 5 directorships: Yatnesh Pharma Private Limited (Director, since 25 Jul 2013, revenue ₹69.60 Cr (FY 2025)); Bsa Tradex Private Limited (Director, since 26 Dec 2018, revenue ₹8.06 Cr (FY 2025)); Neelkanth Pharmaceuticals Llp (Designated Partner, since 19 Dec 2025); Neelkanth Biotech Private Limited (Director, since 07 Feb 2025); Jabs Healthcare Private Limited (Director, since 07 Jul 2022).
Bhupender Kumar was first appointed on 25 Jul 2013 as Director at Yatnesh Pharma Private Limited. The most recent appointment on record is 19 Dec 2025 at Neelkanth Pharmaceuticals Llp.
The 2 current companies of Bhupender Kumar that report revenue have a combined latest revenue of ₹77.67 Cr: Yatnesh Pharma Private Limited ₹69.60 Cr (FY 2025); Bsa Tradex Private Limited ₹8.06 Cr (FY 2025).
The current boards of Bhupender Kumar's companies include Bimla Garg (Yatnesh Pharma Private Limited), Sanjeev Gupta (Bsa Tradex Private Limited), Jitender (Neelkanth Pharmaceuticals Llp), Ashwani Garg (Jabs Healthcare Private Limited).